Published in AIDS Weekly, June 5th, 2006
Researchers in England conducted a study "to determine whether long-term HAART in chronic HIV-1 infection restores fully functional Mycobacterium tuberculosis (MTB)-specific CD4 T-cell responses.
"[This was] a cross-sectional study of HIV-1-seropositive subjects on continuous HAART for over one year with CD4 cell counts >300 cells/microliter and undetectable viremia, antiretroviral-naive individuals with primary HIV-1 infection (PHI), and healthy bacillus Calmette-Guerin-vaccinated low-risk...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.